Perfil
Martin P.
Redmon is currently the Chief Research & Development Officer at Stealth BioTherapeutics Corp.
He previously held the position of Senior Vice President-Research & Development at PreCision Dermatology, Inc. and Chief Research & Development Officer at Stealth BioTherapeutics, Inc. Dr. Redmon obtained undergraduate and doctorate degrees from the University of Kentucky.
Cargos activos de Martin Redmon
| Empresas | Cargo | Inicio |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Director Técnico/Científico/I+D | 16/03/2021 |
Antiguos cargos conocidos de Martin Redmon.
| Empresas | Cargo | Fin |
|---|---|---|
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Director Técnico/Científico/I+D | - |
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Director Técnico/Científico/I+D | - |
Formación de Martin Redmon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
- Bolsa de valores
- Insiders
- Martin Redmon
















